0 results available. Select is focused ,type to refine list, press Down to open the menu,
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology,...
The following section summarizes insights on Bristol-Myers Squibb Co's Relative Strength Index (14d):
We've identified the following companies as similar to Bristol-Myers Squibb Co because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Relative Strength Index (14d) |
|---|---|---|
| Bristol-Myers Squibb Co | BRSE:BMY | - |
| GelStat Corp. | OTCPK:GSAC | - |
| Teva Pharma Industries Ltd ADR | NYSE:TEVA | 23.64 |
| Pfizer Inc | NYSE:PFE | 24.73 |
| Nuvation Bio Inc | NYSE:NUVB | 29.20 |
| Merck & Company Inc | NYSE:MRK | 30.14 |
| Healthcare | SECTOR:HLTH.US | 35.50 |
| Zoetis Inc | NYSE:ZTS | 36.31 |
| AstraZeneca PLC | OTCPK:AZNC.F | 38.53 |
| Johnson & Johnson | NYSE:JNJ | 39.77 |
| Novartis AG ADR | NYSE:NVS | 40.31 |
| Emmaus Life Sciences Inc | OTCPK:EMMA | 46.90 |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Relative Strength Index (14d) in the valuation category include:
A momentum oscillator that measures the speed and change of price movements.
Relative Strength Index (14D) is a momentum oscillator that measures the speed and change of price movements.
We use a most popular implementation of RSI which looks at a 14-day timeframe. Index scores range from 0 to 100, where the stock is considered overbought when the index is above 70 and oversold when below 30.
RSI was described in J. Welles Wilder’s published work, New Concepts in Technical Trading Systems, and in Commodities magazine in the June 1978 issue and has last the test of time becoming one of the more widely used oscillator indices. Read more about relative strength index here.
The chart above depicts the distribution of relative strength index (14d) for companies operating in the Healthcare sector in the Developed economic region. Over 2,580 companies were considered in this analysis, and 2,535 had meaningful values. The average relative strength index (14d) of companies in the sector is 40.23 with a standard deviation of 16.57.
Bristol-Myers Squibb Co's Relative Strength Index (14d) of - is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,587 |
| Included Constituents | 2,535 |
| Min | 13.90 |
| Max | 100.00 |
| Median | 37.50 |
| Mean | 40.23 |
| Standard Deviation | 16.57 |
You can find companies with similar relative strength index (14d) using this stock screener.